CHARLES RIVER LABORATORIES INTERNATIONAL, INC. — Director's Dealing 2020

Feb 11, 2020

SEC Form 5/A — Form 5/A

Issuer: CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)
CIK: 0001100682
Period of Report: 2019-12-28

Reporting Person: FOSTER JAMES C (Director, Chairman, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-07-01	Common Stock	G	2500	—	Disposed	274515	Direct
2019-09-17	Common Stock	G	4775	—	Disposed	0	Indirect
2019-09-24	Common Stock	G	3000	—	Disposed	274515	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	12800	Indirect
Common Stock	340	Indirect
Common Stock	4500	Indirect
Common Stock	1500	Indirect
Common Stock	10000	Indirect
Common Stock	25000	Indirect

Footnotes

F1: On 9/17/2019: 13,615 shares were transferred from the 2017 GRAT to Direct Holdings.

F2: On 10/23/2019, the reporting person contributed 25,000 shares of CRL common stock to a grantor retained annuity trust for the benefit of himself and his two adult children.

F3: On 10/08/2019: 12,200 shares were transferred from the 2018 GRAT to Direct Holdings.

F4: Held by trust of which the reporting person is trustee. These shares are held in a trust for the benefit of the reporting person's immediate family members. The reporting person disclaims beneficial ownership of these securities.

F5: Held by trust of which the reporting person is trustee. The reporting person disclaims beneficial ownership of these securities.

F6: The original Form 5, filed on February 7, 2020, is being amended by this Form 5 amendment solely certain of to correct an administrative error, which resulted in the omission of beneficial ownership of certain shares held by trust.